Mamoru Hasegawa

11.2k citations

197 papers · 8.5k indexed · 3 hit papers · h-index 42

Molecular Biology top 1%
Genetics top 1%
Surgery top 5%
Immunology top 5%
Oncology top 5%

Co-authors: Noemi Fusaki Hiroshi Ban Koichi Saeki Akiyo Nishiyama Makoto Inoue Yoshikazu Yonemitsu Yoshiyuki Nagai Akihiro Iida
Topics: Virus-based gene therapy research (70 papers)RNA Interference and Gene Delivery (22 papers)CRISPR and Genetic Engineering (21 papers)
Cited by: Molecular Biology Virology Genetics
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Japan United States United Kingdom

In The Last Decade

Mamoru Hasegawa

193 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

2009 944 citations Noemi Fusaki, Hiroshi Ban et al. profile →
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor

1991 679 citations Mamoru Hasegawa et al. profile →
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

2011 472 citations Noemi Fusaki, Mamoru Hasegawa et al. profile →

Peers

Countries citing papers authored by Mamoru Hasegawa

Since Specialization

Citations

This map shows the geographic impact of Mamoru Hasegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Hasegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Hasegawa more than expected).

Fields of papers citing papers by Mamoru Hasegawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Hasegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Hasegawa. The network helps show where Mamoru Hasegawa may publish in the future.

Co-authorship network of co-authors of Mamoru Hasegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Hasegawa. A scholar is included among the top collaborators of Mamoru Hasegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Hasegawa. Mamoru Hasegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TLR7 Ligand Augments GM-CSF–Initiated Antitumor Immunity through Activation of Plasmacytoid Dendritic Cells 2014 ·Cancer Immunology Research ·(unknown),Hiroyuki Inoue,Chika Sakamoto,Yumiko Matsumura,Atsushi Takahashi,Tomoko Inoue,Ayumi Watanabe,Shohei Miyamoto,Yoshie Miura,(unknown),Yoshihiro Tanaka,Makoto Inoue,Koichi Takayama,Toshihiko Okazaki,Mamoru Hasegawa,Yoichi Nakanishi,Kenzaburo Tani	15
2	Induced Pluripotent Stem Cell Reprogramming by Integration-Free Sendai Virus Vectors from Peripheral Blood of Patients with Craniometaphyseal Dysplasia 2013 ·Cellular Reprogramming ·I‐Ping Chen,Keiichi Fukuda,Noemi Fusaki,Akihiro Iida,Mamoru Hasegawa,Alexander C. Lichtler,Ernst Reichenberger	40
3	Genetically Modified Adipose Tissue-Derived Stem/Stromal Cells, Using Simian Immunodeficiency Virus-Based Lentiviral Vectors, in the Treatment of Hemophilia B 2013 ·Human Gene Therapy ·Natsumi Watanabe,Kazuo Ohashi,Kohei Tatsumi,Rie Utoh,In Kyong Shim,(unknown),Yuji Kashiwakura,Tsukasa Ohmori,Yoichi Sakata,Makoto Inoue,Mamoru Hasegawa,Teruo Okano	15
4	DVC1-0101 to Treat Peripheral Arterial Disease: A Phase I/IIa Open-label Dose-escalation Clinical Trial 2013 ·Molecular Therapy ·Yoshikazu Yonemitsu,Takuya Matsumoto,Ito H,Jin Okazaki,(unknown),Kumi Yoshida,Mitsuho Onimaru,Toshihiro Onohara,Hiroyuki Inoguchi,Ryoichi Kyuragi,Mototsugu Shimokawa,Hiroshi Ban,Michiko Tanaka,Makoto Inoue,Tsugumine Shu,Mamoru Hasegawa,Yoichi Nakanishi,Yoshihiko Maehara	38
5	Feeder-Free and Serum-Free Production of Hepatocytes, Cholangiocytes, and Their Proliferating Progenitors from Human Pluripotent Stem Cells: Application to Liver-Specific Functional and Cytotoxic Assays 2012 ·Cellular Reprogramming ·Naoko Nakamura,Kumiko Saeki,(unknown),Satoko Matsuyama,Miwako Nishio,Koichi Saeki,Mamoru Hasegawa,Yoshitaka Miyagawa,(unknown),Nobutaka Kiyokawa,Masashi Toyoda,Hidenori Akutsu,Akihiro Umezawa,Akira Yuo	33
6	Production of Functional Classical Brown Adipocytes from Human Pluripotent Stem Cells using Specific Hemopoietin Cocktail without Gene Transfer 2012 ·Cell Metabolism ·Miwako Nishio,Takeshi Yoneshiro,Masako Nakahara,Shinnosuke Suzuki,Koichi Saeki,Mamoru Hasegawa,Yuko Kawai,Hidenori Akutsu,Akihiro Umezawa,Kazuki Yasuda,Kazuyuki Tobe,Akira Yuo,Kazuo Kubota,Masayuki Saito,Kumiko Saeki	132
7	Assessment of F/HN-Pseudotyped Lentivirus as a Clinically Relevant Vector for Lung Gene Therapy 2012 ·American Journal of Respiratory and Critical Care Medicine ·Uta Griesenbach,Makoto Inoue,Cuixiang Meng,Raymond Farley,Mario Chan,(unknown),Andrea M. Brum,Jun You,(unknown),Amelia Shoemark,Alan Boyd,Jane C. Davies,Tracy Higgins,Deborah R. Gill,Stephen C. Hyde,J. Alastair Innes,David J. Porteous,Mamoru Hasegawa,Eric W.F.W. Alton	79
8	Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors 2011 ·Proceedings of the National Academy of Sciences ·Hiroshi Ban,Naoki Nishishita,Noemi Fusaki,Toshiaki Tabata,Koichi Saeki,Masayuki Shikamura,Nozomi Takada,Makoto Inoue,Mamoru Hasegawa,Shin Kawamata,Shin-Ichi Nishikawa	420
9	Inhibition of Choroidal Neovascularization via Brief Subretinal Exposure to a Newly Developed Lentiviral Vector Pseudotyped with Sendai Viral Envelope Proteins 2009 ·Human Gene Therapy ·Yusuke Murakami,Yasuhiro Ikeda,Yoshikazu Yonemitsu,Masanori Miyazaki,Makoto Inoue,Mamoru Hasegawa,Katsuo Sueishi,Tatsuro Ishibashi	34
10	Sustained and NK/CD4+ T Cell-Dependent Efficient Prevention of Lung Metastasis Induced by Dendritic Cells Harboring Recombinant Sendai Virus 2009 ·The Journal of Immunology ·Atsushi Komaru,Yasuji Ueda,(unknown),(unknown),Kumi Yoshida,Tomonori Kato,Hiroaki Kinoh,Yui Harada,Hiroyoshi Suzuki,Makoto Inoue,Mamoru Hasegawa,Tomohiko Ichikawa,Yoshikazu Yonemitsu	31
11	Knockout Serum Replacement (KSR) Has a Suppressive Effect on Sendai Virus-Mediated Transduction of Cynomolgus ES Cells 2008 ·Cloning and Stem Cells ·Yukiko Kishi,Makoto Inoue,Yujiro Tanaka,Hiroaki Shibata,Shigeo Masuda,Tamako Ikeda,Mamoru Hasegawa,Yutaka Hanazono	2
12	Non‐transmissible Sendai virus encoding granulocyte macrophage colony‐stimulating factor is a novel and potent vector system for producing autologous tumor vaccines 2008 ·Cancer Science ·Hiroyuki Inoue,Mutsunori Iga,(unknown),(unknown),(unknown),Shinji Okano,Makoto Inoue,Hiroaki Kinoh,Toyomasa Katagiri,Koichi Takayama,Yoshikazu Yonemitsu,Mamoru Hasegawa,Yusuke Nakamura,Yoichi Nakanishi,Kenzaburo Tani	15
13	Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences 2007 ·Microbes and Infection ·(unknown),Hiroko Igarashi,Akiko Takeda,Tetsuo Tsukamoto,Miki Kawada,Hiroyuki Yamamoto,Makoto Inoue,Akihiro Iida,Tsugumine Shu,Mamoru Hasegawa,Yoshiyuki Nagai,Tetsuro Matano	10
14	Induction of Efficient Antitumor Immunity Using Dendritic Cells Activated by Recombinant Sendai Virus and Its Modulation by Exogenous IFN -β Gene 2006 ·The Journal of Immunology ·Satoko Shibata,Shinji Okano,Yoshikazu Yonemitsu,Mitsuho Onimaru,Shihoko Sata,(unknown),Makoto Inoue,(unknown),Mamoru Hasegawa,Yoichi Moroi,Masutaka Furue,Katsuo Sueishi	57
15	Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats 2002 ·The Journal of Immunology ·Akihisa Yamashita,Yoshikazu Yonemitsu,Shinji Okano,Kazunori Nakagawa,Yutaka Nakashima,T. Irisa,Yukihide Iwamoto,Yoshiyuki Nagai,Mamoru Hasegawa,Katsuo Sueishi	101
16	Highly Efficient Gene Transfer into Primate Embryonic Stem Cells with a Simian Lentivirus Vector 2002 ·Molecular Therapy ·Takayuki Asano,Yutaka Hanazono,Yasuji Ueda,Shin‐ichi Muramatsu,Akihiro Kume,Hirofumi Suemori,Yutaka Suzuki,Yasushi Kondo,Kiyonori Harii,Mamoru Hasegawa,Norio Nakatsuji,Keiya Ozawa	34
17	An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA 2002 ·Journal of Virological Methods ·Takahiro Hirata,Akihiro Iida,Takako Shiraki-Iida,Kaio Kitazato,Atsushi Kato,Yoshiyuki Nagai,Mamoru Hasegawa	20
18	Immunochemical characterisation and epitope mapping of a novel fimbrial protein (Pg-II fimbria) ofPorphyromonas gingivalis 1995 ·FEMS Immunology & Medical Microbiology ·Tomohiko Ogawa,Kenji Yasuda,Keiko Yamada,(unknown),Keiko Ochiai,Mamoru Hasegawa	20
19	Molecular cloning and characterization of the genes encoding the immunoreactive major cell-surface proteins ofPorphyromonas gingivalis 1994 ·FEMS Microbiology Letters ·Tomohiko Ogawa,(unknown),Kenji Yasuda,Mamoru Hasegawa	17
20	Organization and nature of fortimicin A (astromicin) biosynthetic genes studied using a cosmid library of Micromonospora olivasterospora DNA 1992 ·Molecular and General Genetics MGG ·Tohru Dairi,Toshio Ohta,Eri Hashimoto,Mamoru Hasegawa	38

About Mamoru Hasegawa

Mamoru Hasegawa is a scholar working on Genetics, Virology and Molecular Biology, having authored 197 papers that have together received 8.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (70 papers), RNA Interference and Gene Delivery (22 papers) and CRISPR and Genetic Engineering (21 papers). The work is most often cited by research in Molecular Biology (5.6k citations), Virology (322 citations) and Genetics (1.8k citations). Mamoru Hasegawa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Noemi Fusaki, Hiroshi Ban, Koichi Saeki, Akiyo Nishiyama, Makoto Inoue, Yoshikazu Yonemitsu, Yoshiyuki Nagai, Akihiro Iida, Katsuo Sueishi and Katsutoshi Sasaki. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact